CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- 4 Grant or award 10% owner acquired 471,698 shares (grant or award)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · New debt or obligation · Other events
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $132.27 ($396,810)
- 4 Planned sale Chief Comm & Corp Aff Officer sold 28,000 shares at an average $131.29 ($3,676,199)
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 13F-HR Other Quarterly Holdings of Institutional Investment Managers
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 1,146 shares (grant or award)
- 4 Grant or award Director acquired 1,146 shares (grant or award)
- 4 Grant or award Director acquired 1,146 shares (grant or award)
- 4 Grant or award Director acquired 1,146 shares (grant or award)
- 4 Grant or award Director acquired 1,146 shares (grant or award)
- 4 Grant or award Director acquired 1,146 shares (grant or award)
Page 4 of 160 · 3,186 filings